The European School of Oncology has lost a supporter, colleague and friend, writes Mike Clarke, who co-chaired ESO’s Systematic Reviews Masterclass alongside Patrick Johnston. With the sudden and unexpected death of Patrick Johnston on 4 [more]
Rates of alcohol-related digestive cancers are expected to increase very rapidly in Europe, according to an alarming new report issued by United European Gastroenterology (UEG) that calls for a new strategic, political and clinical effort: «It [more]
Cancer control measures that have contributed to increase life expectancy in rich populations have yet to be seen in poorer populations, according to a study just published on The BMJ by a group led by [more]
Gaborone – Botswana’s cancer conscious cyclists – Team Chainring have embarked on a 1000 kilometres ‘Ride for Pink’ to create awareness and raise funds for the Cancer Association of Botswana (CAB). The cyclists’ 1000 kilometres [more]
Thousands of cancer patients in Kenya die prematurely due to lack of treatment. In a country where health insurance is a preserve of the wealthy, most patients are forced to sell their cows or land [more]
My first cancer experience came in September 2014. Then the second cancer followed, to finish what the first has left … There were long surgeries, chemotherapies, double mastectomy, dark thoughts, pain, despair. And I always [more]
“The Big Four of the Millennium” was recently announced at the 61st Congress of the German Society of Gynaecology and Obstetrics. This honor identifies four individuals, whose life’s work created the standards of women’s health [more]
“The first time I felt a little awkward because I had never seen a breast with mastectomy and it was not an easy case. This woman had undergone many surgeries in her effort to make [more]
Pembrolizumab is the first drug approved by the U.S. Food and Drug Administration for use based on a biomarker (a specific genetic feature) rather than the location in the body where the tumor originated. The drug is indicated [more]
May was awash with news stories about blood tests for prostate cancer. Reports that a new serum test called IsoPSA could predict prostate cancer more precisely than conventional PSA testing brought obvious interest. The new [more]
According to an analysis just published on American Cancer Society’s CA: A Cancer Journal for Clinicians, rare cancers account for almost a fifth of all new diagnoses, and up to over two thirds of all new diagnoses [more]
An ESO task force met to discuss the potential for “biosimilar” medical products in oncology, analyzing facts and debunking some myths. Some of the most used biologic drugs in oncology are going off patent in [more]
ESO’s brochure “Who’s Who and Programmes 2017” is now available (click on the image to download the pdf).